InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Inner East Community Finance Limited
Forum | Tag | Subject | View | Poster | |||||
---|---|---|---|---|---|---|---|---|---|
NSX - By Stock | IEC | Ann:On-Market Share Buy-Back Update | Thread | NSX News | 0 | 0 | 0 | 11/09/24 | |
|
|||||||||
NSX - By Stock | IEC | Ann:2024 Preliminary Final Report (Price Sensitive) | Thread | NSX News | 0 | 0 | 0 | 11/09/24 | |
|
|||||||||
NSX - By Stock | IEC | Ann:2024 Dividend Announcement (Price Sensitive) | Thread | NSX News | 0 | 0 | 0 | 11/09/24 | |
|
|||||||||
NSX - By Stock | IEC | Ann:Notice of AGM | Thread | NSX News | 0 | 0 | 0 | 11/09/24 | |
|